MOUNTAINEER: Open-label, phase II study of tucatinib combined with trastuzumab for HER2-positive metastatic colorectal cancer Meeting Abstract


Authors: Strickler, J.; Ng, K.; Cercek, A.; Fountzilas, C.; Sanchez, F.; Hubbard, J.; Wu, C.; Stecher, M.; Walker, L. N.; Bekaii-Saab, T.
Abstract Title: MOUNTAINEER: Open-label, phase II study of tucatinib combined with trastuzumab for HER2-positive metastatic colorectal cancer
Meeting Title: ESMO Virtual Congress 2020
Journal Title: Annals of Oncology
Volume: 31
Issue: Suppl. 4
Meeting Dates: 2020 Sep 19-21/Oct 16-18
Meeting Location: Virtual
ISSN: 0923-7534
Publisher: Oxford University Press  
Date Published: 2020-09-01
Start Page: S460
End Page: S461
Language: English
ACCESSION: WOS:000573469100521
DOI: 10.1016/j.annonc.2020.08.2066
PROVIDER: wos
Notes: Meeting Abstract: 523TiP -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors